Vistance Networks (VISN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Apr, 2026Executive summary
Completed sale of CCS segment to Amphenol in January 2026, using $10 billion in proceeds to repay all debt and redeem preferred equity.
Renamed to Vistance Networks, now focused on Aurora Networks and Ruckus Networks.
Delivered strong growth in both revenue and adjusted EBITDA for 2025, exceeding guidance.
Ended Q4 2025 with $923 million in cash, up $218 million from the previous quarter.
Announced special cash distribution of at least $10 per share to shareholders by April 2026.
Financial highlights
Q4 2025 core net sales: $515 million, up 24% year-over-year; full-year core net sales: $1.93 billion, up 40%.
Q4 2025 core adjusted EBITDA: $99 million, up 55%; full-year core adjusted EBITDA: $379 million, up 176%.
Adjusted EPS for 2025: $0.77 vs $0.10 in 2024; Q4 adjusted EPS: $0.17 vs $0.14 in Q4 2024.
Cash at year-end: $923 million, liquidity at $1.54 billion.
Free cash flow for Q4: $255 million; full-year free cash flow: $252.6 million.
Outlook and guidance
2026 core adjusted EBITDA projected at $350–$400 million, including ~$30 million stranded costs.
Special cash distribution of at least $10 per share planned by April 2026.
Ruckus expected to deliver low teen adjusted EBITDA growth; Aurora EBITDA to decline as legacy business normalizes.
Aurora revenue expected to increase in 2026, but EBITDA to decline due to mix and stranded costs.
Ruckus revenue expected to grow in the mid-teens, outpacing the market.
Latest events from Vistance Networks
- Q1 sales up 22%, RUCKUS sale and $10/share payout highlight strong, debt-free quarter.VISN
Q1 20264 May 2026 - Director elections, executive pay, auditor ratification, and incentive plan shares up for vote.VISN
Proxy filing23 Mar 2026 - Proxy outlines director elections, executive pay, auditor ratification, and major ESG progress.VISN
Proxy filing23 Mar 2026 - Adjusted EBITDA up nearly 20% as CCS growth offsets declines; $2.1B OWN/DAS sale to aid liquidity.VISN
Q2 20242 Feb 2026 - Core adjusted EBITDA rose 25% on strong CCS gains; OWN and DAS divestiture set for Q1 2025.VISN
Q3 202416 Jan 2026 - Core adjusted EBITDA up 159% on 23.5% sales growth; 2025 guidance reaffirmed.VISN
Q1 202524 Dec 2025 - Q4 core sales jumped 27% and margins rose, with 2025 EBITDA guidance at $1.00–$1.05B.VISN
Q4 202421 Dec 2025 - Definitive agreement to sell CCS segment to Amphenol, pending shareholder approval and regulatory review.VISN
Proxy Filing2 Dec 2025 - CCS business sale unlocks equity, enables debt repayment, and sets up a major shareholder dividend.VISN
Proxy Filing1 Dec 2025